New mechanisms of bacterial resistance to antimicrobial agents

New England Journal of Medicine

Volumn 324, Issue 9, 1991, Pages 601-612

  Epstein, Franklin H ^a   Jacoby, George A ^b   Archer, Gordon L ^c  

^a Massachusetts General Hospital ^*

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBENICILLIN; CEFAMANDOLE; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLINDAMYCIN; ERYTHROMYCIN; GENTAMICIN; IMIPENEM; KANAMYCIN; LATAMOXEF; METICILLIN; NAFCILLIN; NETILMICIN; NORFLOXACIN; OXACILLIN; PENICILLIN G; PIPERACILLIN; PSEUDOMONIC ACID; RIFAMPICIN; SPECTINOMYCIN; STREPTOMYCIN; SULFONAMIDE; TETRACYCLINE; TICARCILLIN; TOBRAMYCIN; TRIMETHOPRIM; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BACTERIUM; DRUG RESISTANCE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; PRIORITY JOURNAL; REVIEW;

ANTIBIOTICS; BACTERIA; DRUG RESISTANCE, MICROBIAL; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025978407     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM199102283240906     Document Type: Review

References (180)

1. Holmberg SD, Solomon SL, Blake PA. Health and economic impacts of antimicrobial resistance. Rev Infect Dis 1987; 9: 1065–78.
2. Levy SB, Burke JP, Wallace CK, eds. Antibiotic use and antibiotic resistance worldwide. Rev Infect Dis 1987; 9: Suppl 3.
3. Phelps CE. Bug/drug resistance: sometimes less is more. Med Care 1989; 27: 194–203.
4. Lester SC, del Pilar Pla M, Wang F, Schael IP, Jiang H, O'Brien TF. The carriage of Escherichia coli resistant to antimicrobial agents by healthy children in Boston, in Caracas, Venezuela, and in Qin Pu, China. N Engl J Med 1990; 323: 285–9.
5. Hummel H, Böck A. Ribosomal changes resulting in antimicrobial resistance. In: Bryan LE, ed. Microbial resistance to drugs. Vol. 91 of Handbook of experimental pharmacology. Berlin, Germany: Springer-Verlag, 1989:193–225.
6. Spratt BG. Resistance to β-lactam antibiotics mediated by alterations of penicillin-binding proteins. In: Bryan LE, ed. Microbial resistance to drugs. Vol. 91 of Handbook of experimental pharmacology. Berlin, Germany: Springer-Verlag, 1989:77–100.
7. Wolfson JS, Hooper DC. Fluoroquinolone antimicrobial agents. Clin Microbiol Rev 1989; 2: 378–424.
8. Ezekiel DH, Hutchins JE. Mutations affecting RNA polymerase associated with rifampicin resistance in Escherichia coli. Nature 1968; 220: 276–7.
9. Wise EM Jr, Abou-Donia MM. Sulfonamide resistance mechanism in Escherichia coli: R plasmids can determine sulfonamide-resistant dihydropteroate synthases. Proc Natl Acad Sci U S A 1975; 72: 2621–5.
10. Manavathu EK, Fernandez CL, Cooperman BS, Taylor DE. Molecular studies on the mechanism of tetracycline resistance mediated by Tet(O). Antimicrob Agents Chemother 1990; 34: 71–7.
11. Huovinen P. Trimethoprim resistance. Antimicrob Agents Chemother 1987; 31: 1451–6.
12. al-Obeid S, Collatz E, Gutmann L. Mechanism of resistance to vancomycin in Enterococcus faecium D366 and Enterococcus faecalis A256. Antimicrob Agents Chemother 1990; 34: 252–6.
13. Davies JE. Aminoglycoside-aminocyclitol antibiotics and their modifying enzymes. In: Lorian V, ed. Antibiotics in laboratory medicine. 2nd ed. Baltimore: Williams & Wilkins, 1986:790–809.
14. Medeiros AA. Plasmid-determined beta-lactamases. In: Bryan LE, ed. Microbial resistance to drugs. Vol. 91 of Handbook of experimental pharmacology. Berlin, Germany: Springer-Verlag, 1989:101–27.
15. Sanders CC. The chromosomal beta-lactamases. In: Bryan LE, ed. Microbial resistance to drugs. Vol. 91 of Handbook of experimental pharmacology. Berlin, Germany: Springer-Verlag, 1989:129–49.
16. Shaw WV. Chloramphenicol acetyltransferase: enzymology and molecular biology. CRC Crit Rev Biochem 1983; 14: 1–46.
17. Nikaido H. Role of the outer membrane of Gram-negative bacteria in antimicrobial resistance. In: Bryan LE, ed. Microbial resistance to drugs. Vol. 91 of Handbook of experimental pharmacology. Berlin, Germany: Springer-Verlag, 1989:1–34.
18. Goldman RC, Capobianco JO. Role of an energy-dependent efflux pump in plasmid pNE24-mediated resistance to 14- and 15-membered macrolides in Staphylococcus epidermidis. Antimicrob Agents Chemother 1990; 34: 1973–80.
19. Levy SB. Evolution and spread of tetracycline resistance determinants. J Antimicrob Chemother 1989; 24: 1–3.
20. Idem. Resistance to the tetracyclines. In: Bryan LE, ed. Antimicrobial drug resistance. Orlando, Fla.: Academic Press, 1984:191–240.
21. Jacoby GA, Swartz MN. Plasmids: microbiologic and clinical importance. Semin Infect Dis 1980; 3: 1–37.
22. Finland M. Emergence of antibiotic-resistant bacteria. N Engl J Med 1955; 253: 909–22, 969–79, 1019–28.
23. Davies J, Smith DI. Plasmid-determined resistance to antimicrobial agents. Annu Rev Microbiol 1978; 32: 469–518.
24. Foster TJ. Plasmid-determined resistance to antimicrobial drugs and toxic metal ions in bacteria. Microbiol Rev 1983; 47: 361–409.
25. Bryan LE, ed. Microbial resistance to drugs. Vol. 91 of Handbook of experimental pharmacology. Berlin, Germany: Springer-Verlag, 1989.
26. Korfmann G, Wiedemann B. Genetic control of β-lactamase production in Enterobacter cloacae. Rev Infect Dis 1988; 10: 793–9.
27. Then RL, Angehrn P. Trapping of nonhydrolyzable cephalosporins by cephalosporinases in Enterobacter cloacae and Pseudomonas aeruginosa as a possible resistance mechanism. Antimicrob Agents Chemother 1982; 21: 711–7.
28. Vu H, Nikaido H. Role of β-lactam hydrolysis in the mechanism of resistance of a β-lactamase-constitutive Enterobacter cloacae strain to expanded-spectrum β-lactams. Antimicrob Agents Chemother 1985; 27: 393–8.
29. Sanders WE Jr, Sanders CC. Inducible β-lactamases: clinical and epidemiologic implications for use of newer cephalosporins. Rev Infect Dis 1988; 10: 830–8.
30. Olsson O, Bergström S, Lindberg FP, Normark S. ampC β-lactamase hyperproduction in Escherichia coli: natural ampicillin resistance generated by horizontal chromosomal DNA transfer from Shigella. Proc Natl Acad Sci U S A 1983; 80: 7556–60.
31. Knothe H, Shah P, Krcméry V, Antal M, Mitsuhashi S. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983; 11: 315–7.
32. Kliebe C, Nies BA, Meyer JF, Tolxdorff-Neutzling RM, Wiedemann B. Evolution of plasmid-coded resistance to broad-spectrum cephalosporins. Antimicrob Agents Chemother 1985; 28: 302–7.
33. Philippon A, Labia R, Jacoby G. Extended-spectrum β-lactamases. Antimicrob Agents Chemother 1989; 33: 1131–6.
34. Philippon A, Ben Redjeb S, Fournier G, Ben Hassen A. Epidemiology of extended spectrum β-lactamases. Infection 1989; 17: 347–54.
35. Jacoby GA, Carreras I. Activities of β-lactam antibiotics against Escherichia coli strains producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 1990; 34: 858–62.
36. Mabilat C, Courvalin P. Development of “oligotyping” for characterization and molecular epidemiology of TEM β-lactamases in members of the family Enterobacteriaceae. Antimicrob Agents Chemother 1990; 34: 2210–6.
37. Gutmann L, Kitzis MD, Billot-Klein D, et al. Plasmid-mediated β-lactamase (TEM-7) involved in resistance to ceftazidime and aztreonam. Rev Infect Dis 1988; 10: 860–6.
38. Sougakoff W, Goussard S, Gerbaud G, Courvalin P. Plasmid-mediated resistance to third-generation cephalosporins caused by point mutations in TEM-type penicillinase genes. Rev Infect Dis 1988; 10: 879–84.
39. Papanicolaou GA, Medeiros AA, Jacoby GA. Novel plasmid-mediated β-lactamase (MIR-1) conferring resistance to oxyimino- and α-methoxy β-lactams in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1990; 34: 2200–9.
40. Yang Y, Wu P, Livermore DM. Biochemical characterization of a β-lactamase that hydrolyzes penems and carbapenems from two Serratia marcescens isolates. Antimicrob Agents Chemother 1990; 34: 755–8.
41. Cuchural GJ Jr, Malamy MH, Tally FP. β-Lactamase-mediated imipenem resistance in Bacteroides fragilis. Antimicrob Agents Chemother 1986; 30: 645–8.
42. Dufresne J, Vézina G, Levesque RC. Cloning and expression of the imipenem-hydrolyzing β-lactamase operon from Pseudomonas maltophilia in Escherichia coli. Antimicrob Agents Chemother 1988; 32: 819–26.
43. Bellido F, Veuthey C, Blaser J, Bauernfeind A, Pechère JC. Novel resistance to imipenem associated with an altered PBP-4 in a Pseudomonas aeruginosa clinical isolate. J Antimicrob Chemother 1990; 25: 57–68.
44. Pierre J, Boisivon A, Gutmann L. Alteration of PBP 3 entails resistance to imipenem in Listeria monocytogenes. Antimicrob Agents Chemother 1990; 34: 1695–8.
45. Trias J, Nikaido H. Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa. Antimicrob Agents Chemother 1990; 34: 52–7.
46. Hopkins JM, Towner KJ. Enhanced resistance to cefotaxime and imipenem associated with outer membrane protein alterations in Enterobacter aerogenes. J Antimicrob Chemother 1990; 25: 49–55.
47. Kernodle DS, Stratton CW, McMurray LW, Chipley JR, McGraw PA. Differentiation of β-lactamase variants of Staphylococcus aureus by substrate hydrolysis profiles. J Infect Dis 1989; 159: 103–8.
48. Kernodle DS, Classen DC, Burke JP, Kaiser AB. Failure of cephalosporins to prevent Staphylococcus aureus surgical wound infections. JAMA 1990; 263: 961–6.
49. McDougal LK, Thomsberry C. The role of β-lactamase in staphylococcal resistance to penicillinase-resistant penicillins and cephalosporins. J Clin Microbiol 1986; 23: 832–9.
50. Chambers HF, Archer G, Matsuhashi M. Low-level methicillin resistance in strains of Staphylococcus aureus. Antimicrob Agents Chemother 1989; 33: 424–8.
51. Massanari RM, Pfaller MA,Wakefield DS, et al. Implications of acquired oxacillin resistance in the management and control of Staphylococcus aureus infections. J Infect Dis 1988; 158: 702–9.
52. Pierre J, Williamson R, Bornet M, Gutmann L. Presence of an additional penicillin-binding protein in methicillin-resistant Staphylococcus epidermidis, Staphylococcus haemolyticus, Staphylococcus hominis, and Staphylococcus simulans with a low affinity for methicillin, cephalothin, and cefamandole. Antimicrob Agents Chemother 1990; 34: 1691–4.
53. Tomasz A, Drugeon HB, de Lencastre HM, Jabes D, McDougall L, Bille J. New mechanism for methicillin resistance in Staphylococcus aureus: clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacity. Antimicrob Agents Chemother 1989; 33: 1869–74.
54. Brumfitt W, Hamilton-Miller J. Methicillin-resistant Staphylococcus aureus. N Engl J Med 1989; 320: 1188–96.
55. Maple PAC, Hamilton-Miller JMT, Brumfitt W. World-wide antibiotic resistance in methicillin-resistant Staphylococcus aureus. Lancet 1989; 1: 537–40.
56. Horan TC, White JW, Jarvis WR, et al. Nosocomial infection surveillance, 1984. MMWR CDC Surveill Summ 1986; 35: 17SS–29SS.
57. Hsu CC, Macaluso CP, Special L, Hubble RH. High rate of methicillin resistance of Staphylococcus aureus isolated from hospitalized nursing home patients. Arch Intern Med 1988; 148: 569–70.
58. Jones RN, Barry AL, Gardiner RV, Packer RR. The prevalence of staphylococcal resistance to penicillinase-resistant penicillins: a retrospective and prospective national surveillance trial of isolates from 40 medical centers. Diagn Microbiol Infect Dis 1989; 12: 385–94.
59. Froggatt JW, Johnston JL, Galetto DW, Archer GL. Antimicrobial resistance in nosocomial isolates of Staphylococcus haemolyticus. Antimicrob Agents Chemother 1989; 33: 460–6.
60. Ubukata K, Nonoguchi R, Matsuhashi M, Konno M. Expression and inducibility in Staphylococcus aureus of the mecA gene, which encodes a methicillin-resistant S. aureus-specific penicillin-binding protein. J Bacteriol 1989; 171: 2882–5.
61. Song MD, Wachi M, Doi M, Ishino F, Matsuhashi M. Evolution of an inducible penicillin-target protein and methicillin-resistant Staphylococcus aureus by gene fusion. FEBS Lett 1987; 221: 167–71.
62. Chambers HF, Hackbarth CJ. Effect of NaCl and nafcillin on penicillin-binding protein 2a and heterogeneous expression of methicillin resistance in Staphylococcus aureus. Antimicrob Agents Chemother 1987; 31: 1982–8.
63. Berger-Bächi B, Barberis-Maino L, Strassle A, Kayser FH. FemA, a host-mediated factor essential for methicillin resistance in Staphylococcus aureus: molecular cloning and characterization. Mol Gen Genet 1989; 219: 263–9.
64. Berger-Bächi B, Kohler M. A novel site on the chromosome of Staphylococcus aureus influencing the level of methicillin resistance: genetic mapping. FEMS Microbiol Lett 1983; 20: 305–9.
65. Tesch W, Ryffel C, Strässle A, Kayser FH, Berger-Bächi B. Evidence of a novel staphylococcal mec-encoded element (mecR) controlling expression of penicillin-binding protein 2′. Antimicrob Agents Chemother 1990; 34: 1703–6.
66. Chambers HF. Methicillin-resistant staphylococci. Clin Microbiol Rev 1988; 1: 173–86.
67. Archer GL, Pennell E. Detection of methicillin resistance in staphylococci by using a DNA probe. Antimicrob Agents Chemother 1990; 34: 1720–4.
68. Fontana R, Canepari P, Lleò MM, Satta G. Mechanisms of resistance of enterococci to beta-lactam antibiotics. Eur J Clin Microbiol Infect Dis 1990; 9: 103–5.
69. Jabes D, Nachman S, Tomasz A. Penicillin-binding protein families: evidence for the clonal nature of penicillin resistance in clinical isolates of pneumococci. J Infect Dis 1989; 159: 16–25.
70. Dowson CG, Hutchison A, Brannigan JA, et al. Horizontal transfer of penicillin-binding protein genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae. Proc Natl Acad Sci U S A 1989; 86: 8842–6.
71. Simberkoff MS, Lukaszewki M, Cross A, et al. Antibiotic-resistant isolates of Streptococcus pneumoniae from clinical specimens: a cluster of serotype 19A organisms in Brooklyn, New York. J Infect Dis 1986; 153: 78–82.
72. Viladrich PF, Gudiol F, Linares J, Rufi G, Ariza J, Pallares R. Characteristics and antibiotic therapy of adult meningitis due to penicillin-resistant pneumococci. Am J Med 1988; 84: 839–46.
73. Pallares R, Gudiol F, Liñares J, et al. Risk factors and response to antibiotic therapy in adults with bacteremic pneumonia caused by penicillin-resistant pneumococci. N Engl J Med 1987; 317: 18–22.
74. Facklam R, Carey R. Streptococci and aerococci. In: Lennette EH, Balows A, Hausler WJ Jr, Shadomy HJ, eds. Manual of clinical microbiology. 4th ed. Washington, D.C.: American Society for Microbiology, 1985:154–75.
75. Mendelman PM, Chaffin DO, Kalaitzoglou G. Penicillin-binding proteins and ampicillin resistance in Haemophilus influenzae. J Antimicrob Chemother 1990; 25: 525–34.
76. Dougherty TJ. Genetic analysis and penicillin-binding protein alterations in Neisseria gonorrhoeae with chromosomally mediated resistance. Antimicrob Agents Chemother 1986; 30: 649–52.
77. Mendelman PM, Campos J, Chaffin DO, Serfass DA, Smith AL, Saez-Nieto JA. Relative penicillin G resistance in Neisseria meningitidis and reduced affinity of penicillin-binding protein 3. Antimicrob Agents Chemother 1988; 32: 706–9.
78. Spratt BG, Zhang Q-Y, Jones DM, Hutchison A, Brannigan JA, Dowson CG. Recruitment of a penicillin-binding protein gene from Neisseria fiavescens during the emergence of penicillin resistance in Neisseria meningitidis. Proc Natl Acad Sci U S A 1989; 86: 8988–92.
79. Spratt BG. Hybrid penicillin-binding proteins in penicillin-resistant strains of Neisseria gonorrhoeae. Nature 1988; 332: 173–6.
80. Handwerger S, Horowitz H, Coburn K, Kolokathis A, Wormser GP. Infection due to Leuconostoc species: six cases and review. Rev Infect Dis 1990; 12: 602–10.
81. Ruoff KL, Kuritzkes DR, Wolfson JS, Ferraro MJ. Vancomycin-resistant gram-positive bacteria isolated from human sources. J Clin Microbiol 1988; 26: 2064–8.
82. Schwalbe RS, Stapleton JT, Gilligan PH. Emergence of vancomycin resistance in coagulase-negative staphylococci. N Engl J Med 1987; 316: 927–31.
83. Leclerq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319: 157–61.
84. Shlaes DM, Bouvet A, Devine C, Shlaes JH, al-Obeid S, Williamson R. Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256. Antimicrob Agents Chemother 1989; 33: 198–203.
85. Reynolds PE. Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur J Clin Microbiol Infect Dis 1990; 8: 943–50.
86. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1988; 1: 57–8.
87. Sahm DF, Kissinger J, Gilmore MS, et al. In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 1989; 33: 1588–91.
88. Gerding DN, Larson TA. Aminoglycoside resistance in gram-negative bacilli during increased amikacin use. Am J Med 1985; 79: Suppl lA: l–7.
89. Vanhoof R, Hubrechts JM, Nyssen HJ, Roebben E. Three-year survey of amikacin use and aminoglycoside resistance in a general hospital in Belgium. Eur J Clin Microbiol Infect Dis 1988; 7: 183–5.
90. Young EJ, Sewell MC, Koza MA, Clarridge JE. Antibiotic resistance patterns during aminoglycoside restriction. Am J Med Sci 1985; 290: 223–7.
91. Levine JF, Maslow MJ, Leibowitz RE, et al. Amikacin-resistant gram-negative bacilli: correlation of occurrence with amikacin use. J Infect Dis 1985; 151: 295–300.
92. Gaynes R, Groisman E, Nelson E, Casadaban M, Lerner SA. Isolation, characterization, and cloning of a plasmid-borne gene encoding a phospho-transferase that confers high-level amikacin resistance in enteric bacilli. Antimicrob Agents Chemother 1988; 32: 1379–84.
93. Jacoby GA, Blaser MJ, Santanam P, et al. Appearance of amikacin and tobramycin resistance due to 4′-aminoglycoside nucleotidyltransferase [ANT(4′)-II] in gram-negative pathogens. Antimicrob Agents Chemother 1990; 34: 2381–6.
94. Maloney J, Rimland D, Stephens DS, Terry P, Whitney AM. Analysis of amikacin-resistant Pseudomonas aeruginosa developing in patients receiving amikacin. Arch Intern Med 1989; 149: 630–4.
95. Lambert T, Gerbaud G, Courvalin P. Transferable amikacin resistance in Acinetobacter spp. due to a new type of 3′-aminoglycoside phosphotransferase. Antimicrob Agents Chemother 1988; 32: 15–9.
96. Lambert T, Gerbaud G, Bouvet P, Vieu J-F, Courvalin P. Dissemination of amikacin resistance gene aphA6 in Acinetobacter spp. Antimicrob Agents Chemother 1990; 34: 1244–8.
97. Kettner M, Macicková T, Navarová J, Krcméry V, Havlík J. Mechanisms of transferable amikacin resistance in enterobacteria in a Czechoslovak clinic. J Antimicrob Chemother 1988; 22: 82–4.
98. Shimizu K, Kumada T, Hsieh W-C, et al. Comparison of aminoglycoside resistance patterns in Japan, Formosa, and Korea, Chile, and the United States. Antimicrob Agents Chemother 1985; 28:282–8.
99. Ubukata K, Yamashita N, Gotoh A, Konno M. Purification and characterization of aminoglycoside-modifying enzymes from Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother 1984; 25: 754–9.
100. Kettner M, Macicková T, Krcméry V. Occurrence of 4′-O-aminoglycoside-nucleotidyltransferase in clinical strains of Enterobacteriaceae. Infection 1989; 17: 100–1.
101. Thorbjarnardóttir SH, Magnúsdóttir RA, Eggertsson G. Mutations determining generalized resistance to aminoglycoside antibiotics in Escherichia coli. Mol Gen Genet 1978; 161: 89–98.
102. Bryan LE, O'Hara K, Wong S. Lipopolysaccharide changes in impermeability-type aminoglycoside resistance in Pseudomonas aeruginosa. Antimicrob Agents Chemother 1984; 26: 250–5.
103. Tran Van Nhieu G, Collatz E. Heterogeneity of 6′-N-acetyltransferases of type 4 conferring resistance to amikacin and related aminoglycosides in members of the family Enterobacteriaceae. Antimicrob Agents Chemother 1988; 32: 1289–91.
104. Ferretti JJ, Gilmore KS, Courvalin P. Nucleotide sequence analysis of the gene specifying the bifunctional 6′-aminoglycoside acetyltransferase 2″-aminoglycoside phosphotransferase enzyme in Streptococcus faecalis and identification and cloning of gene regions specifying the two activities. J Bacteriol 1986; 167: 631–8.
105. Thomas WD Jr, Archer GL. Mobility of gentamicin resistance genes from staphylococci isolated in the United States: identification of Tn4031, a gentamicin resistance transposon from Staphylococcus epidermidis. Antimicrob Agents Chemother 1989; 33: 1335–41.
106. Lyon BR, Skurray R. Antimicrobial resistance of Staphylococcus aureus: genetic basis. Microbiol Rev 1987; 51: 88–134.
107. Forbes BA, Schaberg DR. Transfer of resistance plasmids from Staphylococcus epidermidis to Staphylococcus aureus: evidence for conjugative exchange of resistance. J Bacteriol 1983; 153: 627–34.
108. Archer GL, Dietrick DR, Johnston JL. Molecular epidemiology of transmissible gentamicin resistance among coagulase-negative staphylococci in a cardiac surgery unit. J Infect Dis 1985; 151: 243–51.
109. Ounissi H, DerlotE, CarlierC, Courvalin P. Gene homogeneity for aminoglycoside-modifying enzymes in gram-positive cocci. Antimicrob Agents Chemother 1990; 34: 2164–8.
110. Patterson JE, Zervos MJ. High-level gentamicin resistance in Enterococcus: microbiology, genetic basis, and epidemiology. Rev Infect Dis 1990; 12: 644–52.
111. Hodel-Christian SL, Murray BE. Mobilization of the gentamicin resistance gene in Enterococcus faecalis. Antimicrob Agents Chemother 1990; 34: 1278–80.
112. Hooper DC, Wolfson JS, Souza KS, Tung C, McHugh GL, Swartz MN. Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli. Antimicrob Agents Chemother 1986; 29: 639–44.
113. Nakamura S, Nakamura M, Kojima T, Yoshida H. gyrA and gyrB mutations in quinolone-resistant strains of Escherichia coli. Antimicrob Agents Chemother 1989; 33: 254–5.
114. Yoshida H, Bogaki M, Nakamura M, Nakamura S. Quinolone resistance-determining region in the DNA gyrase gyrA gene of Escherichia coli. Antimicrob Agents Chemother 1990; 34: 1271–2.
115. Hooper DC, Wolfson JS, Souza KS, Ng EY, McHugh GL, Swartz MN. Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation. Antimicrob Agents Chemother 1989; 33: 283–90.
116. Cohen S, Hooper DC, Wolfson JS, Souza KS, McMurry LM, Levy SB. Endogenous active efflux of norfloxacin in susceptible Escherichia coli. Antimicrob Agents Chemother 1988; 32: 1187–91.
117. Courvalin P. Plasmid-mediated 4-quinolone resistance: a real or apparent absence? Antimicrob Agents Chemother 1990; 34: 681–4.
118. Cohen SP, McMurry LM, Hooper DC, Wolfson JS, Levy SB. Cross-resistance to fluoroquinolones in multiple-antibiotic resistant (Mar) Escherichia coli selected by tetracycline or chloramphenicol: decreased drug accumulation associated with membrane changes in addition to OmpF reduction. Antimicrob Agents Chemother 1989; 33: 1318–25.
119. Sanders CC, Sanders WE Jr, Goering RV, Werner V. Selection of multiple antibiotic resistance by quinolones, β-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes. Antimicrob Agents Chemother 1984; 26: 797–801.
120. Harder KJ, Nikaido H, Matsuhashi M. Mutants of Escherichia coli that are resistant to certain beta-lactam compounds lack the ompF porin. Antimicrob Agents Chemother 1981; 20: 549–52.
121. Jaffé A, Chabbert YA, Derlot E. Selection and characterization of β-lactam-resistant Escherichia coli K-12 mutants. Antimicrob Agents Chemother 1983; 23: 622–5.
122. George AM, Levy SB. Amplifiable resistance to tetracycline, chloramphenicol, and other antibiotics in Escherichia coli: involvement of a non-plasmid-determined efflux of tetracycline. J Bacteriol 1983; 155: 531–40.
123. Robillard NJ, Scarpa AL. Genetic and physiological characterization of ciprofloxacin resistance in Pseudomonas aeruginosa PAO. Antimicrob Agents Chemother 1988; 32: 535–9.
124. Chamberland S, Bayer AS, Schollaardt T, Wong SA, Bryan LE. Characterization of mechanisms of quinolone resistance in Pseudomonas aeruginosa strains isolated in vitro and in vivo during experimental endocarditis. Antimicrob Agents Chemother 1989; 33: 624–34.
125. Gutmann L, Williamson R, Moreau N, et al. Cross-resistance to nalidixic acid, trimethoprim, and chloramphenicol associated with alterations in outer membrane proteins of Klebsiella, Enterobacter, and Serratia. J Infect Dis 1985; 151: 501–7.
126. Aoyama H, Fujimaki K, Sato K, et al. Clinical isolate of Citrobacter freundii highly resistant to new quinolones. Antimicrob Agents Chemother 1988; 32: 922–4.
127. Sanders CC, Watanakunakom C. Emergence of resistance to β-lactams, aminoglycosides, and quinolones during combination therapy for infection due to Serratia marcescens. J Infect Dis 1986; 153: 617–9.
128. Daikos GL, Lolans VT, Jackson GG. Alterations in outer membrane proteins of Pseudomonas aeruginosa associated with selective resistance to quinolones. Antimicrob Agents Chemother 1988; 32: 785–7.
129. Kresken M, Wiedemann B. Development of resistance to nalidixic acid and the fluoroquinolones after the introduction of norfloxacin and ofloxacin. Antimicrob Agents Chemother 1988; 32: 1285–8.
130. Schaefler S. Methicillin-resistant strains of Staphylococcus aureus resistant to quinolones. J Clin Microbiol 1989; 27: 335–6.
131. Kotilainen P, Nikoskelainen J, Huovinen P. Emergence of ciprofloxacin-resistant coagulase-negative staphylococcal skin flora in immunocompromised patients receiving ciprofloxacin. J Infect Dis 1990; 161: 41–4.
132. Datta N, Hughes VM. Plasmids of the same Inc groups in Enterobacteria before and after the medical use of antibiotics. Nature 1983; 306: 616–7.
133. Kleckner N. Transposable elements in prokaryotes. Annu Rev Genet 1981; 15: 341–404.
134. Stokes HW, Hall RM. A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons. Mol Microbiol 1989; 3: 1669–83.
135. Martinez E, de la Cruz F. Genetic elements involved in Tn21 site-specific integration, a novel mechanism for the dissemination of antibiotic resistance genes. EMBO J 1990; 9: 1275–81.
136. Mercier J, Lachapelle J, Couture F, et al. Structural and functional characterization of tnpI, a recombinase locus in Tn21 and related β-lactamase transposons. J Bacteriol 1990; 172: 3745–57.
137. Lowbury EJL, Babb JR, Roe E. Clearance from a hospital of gram-negative bacilli that transfer carbenicillin-resistance to Pseudomonas aeruginosa. Lancet 1972; 2: 941–5.
138. Cookson BD. Mupirocin resistance in staphylococci. J Antimicrob Chemother 1990; 25: 497–503.
139. Sreedharan S, Oram M, Jensen B, Peterson LR, Fisher LM. DNA gyrase gyrA mutations in ciprofloxacin-resistant strains of Staphylococcus aureus: close similarity with quinolone resistance mutations in Escherichia coli. J Bacteriol 1990; 172: 7260–2.
140. Yoshida H, Bogaki M, Nakamura S, Ubukata K, Konno M. Nucleotide sequence and characterization of the Staphylococcus aureus norA gene, which confers resistance to quinolones. J Bacteriol 1990; 172: 6942–9.
141. Barberis-Maino L, Berger-Bächi B, Weber H, Beck WD, Kayser FH. IS431, a staphylococcal insertion sequence-like element related to IS26 from Proteus vulgaris. Gene 1987; 59: 107–13.
142. Gillespie MT, Lyon BR, Loo LSL, Matthews PR, Stewart PR, Skurray RA. Homologous direct repeat sequences associated with mercury, methicillin, tetracycline and trimethoprim resistance determinants in Staphylococcus aureus. FEMS Microbiol Lett 1987; 43: 165–71.
143. Benveniste R, Davies J. Aminoglycoside antibiotic-inactivating enzymes in actinomycetes similar to those present in clinical isolates of antibiotic-resistant bacteria. Proc Natl Acad Sci U S A 1973; 70: 2276–80.
144. Thompson CJ, Gray GS. Nucleotide sequence of a streptomycete aminoglycoside phosphotransferase gene and its relation to phosphotransferases encoded by resistance plasmids. Proc Natl Acad Sci U S A 1983; 80: 5190–4.
145. Ambler RP. The structure of β-lactamases. Philos Trans R Soc Lond [Biol] 1980; 289: 321–31.
146. Trieu-Cuot P, Courvalin P. Evolution and transfer of aminoglycoside resistance genes under natural conditions. J Antimicrob Chemother 1986; 18: Suppl C: 93–102.
147. Roberts MC. Characterization of the Tet M determinants in urogenital and respiratory bacteria. Antimicrob Agents Chemother 1990; 34: 476–8.
148. Roberts MC, Kenny GE. Conjugal transfer of transposon Tn916 from Streptococcus faecalis to Mycoplasma hominis. J Bacteriol 1987; 169: 3836–9.
149. Hedges RW, Jacob AE. Transposition of ampicillin resistance from RP4 to other replicons. Mol Gen Genet 1974; 132: 31–40.
150. Brunton J, Meier M, Erhman N, Clare D, Almawy R. Origin of small β-lactamase-specifying plasmids in Haemophilus species and Neisseria gonorrhoeae. J Bacteriol 1986; 168: 374–9.
151. Doern GV, Jorgensen JH, Thornsberry C, et al. National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother 1988; 32: 180–5.
152. Moran JS, Zenilman JM. Therapy for gonococcal infections: options in 1989. Rev Infect Dis 1990; 12: S633–S644.
153. Fontanals D, Pineda V, Pons I, Rojo JC. Penicillin-resistant beta-lactamase producing Neisseria meningitidis in Spain. Eur J Clin Microbiol Infect Dis 1989; 8: 90–1.
154. Murray BE, Mederski-Samoraj BD. Transferable β-lactamase: a new mechanism for in vitro penicillin resistance in Streptococcus faecalis. J Clin Invest 1983; 72: 1168–71.
155. Patterson JE, Wanger A, Zscheck KK, Zervos MJ, Murray BE. Molecular epidemiology of β-lactamase-producing enterococci. Antimicrob Agents Chemother 1990; 34: 302–5.
156. Murray BE, Mederski-Samoraj B, Foster SK, Brunton JL, Harford P. In vitro studies of plasmid-mediated penicillinase from Streptococcus faecalis suggest a staphylococcal origin. J Clin Invest 1986; 77: 289–93.
157. Joly-Guillou ML, Bergogne-Bérézin E, Moreau N. Enzymatic resistance to β-lactams and aminoglycosides in Acinetobacter calcoaceticus. J Antimicrob Chemother 1987; 20: 773–6.
158. Wexler HM, Finegold SM. Antimicrobial resistance in Bacteroides. J Antimicrob Chemother 1987; 19: 143–6.
159. Park BH, Hendricks M, Malamy MH, Tally FP, Levy SB. Cryptic tetracycline resistance determinant (class F) from Bacteroides fragilis mediates resistance in Escherichia coli by actively reducing tetracycline accumulation. Antimicrob Agents Chemother 1987; 31: 1739–43.
160. Breuil J, Dublanchet A, Truffaut N, Sebald M. Transferable 5-nitroimidazole resistance in the Bacteroides fragilis group. Plasmid 1989; 21: 151–4.
161. Taylor DE, Courvalin P. Mechanisms of antibiotic resistance in Campylobacter species. Antimicrob Agents Chemother 1988; 32: 1107–12.
162. Rood JI, Jefferson S, Bannam TL, Wilkie JM, Mullany P, Wren BW. Hybridization analysis of three chloramphenicol resistance determinants from Clostridium perfringens and Clostridium difficile. Antimicrob Agents Chemother 1989; 33: 1569–74.
163. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990; 3: 46–65.
164. Dangor Y, Ballard RC, Miller SD, Koornhof HJ. Antimicrobial susceptibility of Haemophilus ducreyi. Antimicrob Agents Chemother 1990; 34: 1303–7.
165. Needham CA. Haemophilus influenzae: antibiotic susceptibility. Clin Microbiol Rev 1988; 1: 218–27.
166. Wallace RJ Jr, Nash DR, Steingrube VA. Antibiotic susceptibilities and drug resistance in Moraxella (Branhamella) catarrhalis. Am J Med 1990; 88:Suppl 5A: 46S–50S.
167. Sareen M, Khuller GK. Cell wall and membrane changes associated with ethambutol resistance in Mycobacterium tuberculosis H37Ra. Antimicrob Agents Chemother 1990; 34: 1773–6.
168. Schwarcz SK, Zenilman JM, Schnell D, et al. National surveillance of antimicrobial resistance in Neisseria gonorrhoeae. JAMA 1990; 264: 1413–7.
169. Morse SA, Johnson SR, Biddle JW, Roberts MC. High-level tetracycline resistance in Neisseria gonorrhoeae is result of acquisition of streptococcal tetM determinant. Antimicrob Agents Chemother 1986; 30: 664–70.
170. Kristiansen B-E, Rådström P, Jenkins A, Ask E, Facinelli B, Sköld O. Cloning and characterization of a DNA fragment that confers sulfonamide resistance in a serogroup B, serotype 15 strain of Neisseria meningitidis. Antimicrob Agents Chemother 1990; 34: 2277–9.
171. Jacoby GA. Resistance plasmids of Pseudomonas. In: Sokatch JR, ed. The biology of Pseudomonas. Vol. 10 of The bacteria: a treatise on structure and function. Orlando, Fla.: Academic Press, 1986:265–93.
172. Prince A, Wood MS, Cacalano GS, Chin NX. Isolation and characterization of a penicillinase from Pseudomonas cepacia 249. Antimicrob Agents Chemother 1988; 32: 838–43.
173. Klugman KP. Pneumococcal resistance to antibiotics. Clin Microbiol Rev 1990; 3: 171–96.
174. Clewell DB. Plasmids, drug resistance, and gene transfer in the genus Streptococcus. Microbiol Rev 1981; 45: 409–36.
175. Horodniceanu T, Buu-Hoï A, Delbos F, Bieth G. High-level aminoglycoside resistance in group A, B, G, D (Streptococcus bovis) and viridans streptococci. Antimicrob Agents Chemother 1982; 21: 176–9.
176. Marr JJ, Moffet HL, Kunin CM. Guidelines for improving the use of antimicrobial agents in hospitals: a statement by the Infectious Diseases Society of America. J Infect Dis 1988; 157: 869–76.
177. Committee on Human Health Risk Assessment of Using Subtherapeutic Antibiotics in Animal Feed. Human health risks with the subtherapeutic use of penicillin or tetracycline in animal feed. Washington, D.C.: National Academy Press, 1989.
178. Gootz TD. Discovery and development of new antimicrobial agents. Clin Microbiol Rev 1990; 3: 13–31.
179. Silver L, Bostian K. Screening of natural products for antimicrobial agents. Eur J Clin Microbiol Infect Dis 1990; 9: 455–61.
180. Eliopoulos GM, Eliopoulis CT. Antibiotic combinations: should they be tested? Clin Microbiol Rev 1988; 1: 139–56.